Amal Dakka
14Patents
4h-index
33Co-inventors
52Inventor score
Filing activity: Dec 28, 2012 → Oct 5, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9399649B2 | Compounds for treating spinal muscular atrophy | Chemistry; Metallurgy | 30 | Active |
| US9617268B2 | Compounds for treating spinal muscular atrophy | Chemistry; Metallurgy | 28 | Active |
| US9586955B2 | Compounds for treating spinal muscular atrophy | Chemistry; Metallurgy | 18 | Active |
| US9879007B2 | Compounds for treating spinal muscular atrophy | Chemistry; Metallurgy | 15 | Active |
| US10501482B2 | Compounds for treating spinal muscular atrophy | Chemistry; Metallurgy | 2 | Active |
| US10668171B2 | Methods for modulating RNA splicing | Emerging Cross-Sectional Technologies | 1 | Active |
| US11602567B2 | Methods for modulating RNA splicing | Emerging Cross-Sectional Technologies | 0 | Active |
| US11608501B2 | Methods for modifying RNA splicing | Chemistry; Metallurgy | 0 | Active |
| US12398140B2 | Substituted pyrrolo [2,3-d]pyrimidines for treating familial dysautonomia | Human Necessities | 0 | Active |
| US11702646B2 | Methods for modulating RNA splicing | Chemistry; Metallurgy | 0 | Active |
| US12384797B2 | Thioeno[3,2-b] pyridin-7-amine compounds for treating familial dysautonomia | Human Necessities | 0 | Active |
| US11753407B2 | Compounds for treating spinal muscular atrophy | Chemistry; Metallurgy | 0 | Active |
| US10851101B2 | Compounds for treating spinal muscular atrophy | Chemistry; Metallurgy | 0 | Active |
| USRE47689E1 | Compounds for treating spinal muscular atrophy | General | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.